Shandong Xinhua (00719) recorded a net profit attributable to the parent company of 83.903 million yuan in the first quarter, a year-on-year decrease of 25.15%.
Shandong Xinhua Pharmaceutical Co., Ltd. (00719) issued an announcement. In the first quarter of 2026, the operating income was 2.423 billion yuan, a year-on-year decrease of 0.28%; the net profit attributable to the shareholders of the listed company was 83.903 million yuan, a year-on-year decrease of 25.15%; the basic earnings per share was 0.12 yuan.
Shandong Xinhua (00719) has released an announcement. In the first quarter of 2026, the operating income was 2.423 billion yuan, a year-on-year decrease of 0.28%; the net profit attributable to shareholders of the listed company was 83.903 million yuan, a year-on-year decrease of 25.15%; basic earnings per share was 0.12 yuan.
Related Articles
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.
UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.
LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.
UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.
LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
